PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
To estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.
Autores Principales: | , , , , |
---|---|
Formato: | Artículo (Article) |
Lenguaje: | Inglés (English) |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/25997 https://doi.org/10.1016/j.jval.2016.03.1586 |